Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Benjamin Westbrook

Thoracic Surgery (Cardiothoracic Vascular Surgery) Manchester, NH Medical Doctor

NPI 1669457503 CMS profile 302189

100 McGregor St, Suite B600a, Manchester, NH 03102

Open in the dashboard

General payments

$6,847

87 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Benjamin Westbrook of Manchester, NH is reported in the CMS Open Payments database as having received $6,847 across 87 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 57th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $124 6
2024 General $220 9
2023 General $2,789 34
2022 General $590 10
2021 General $1,889 12
2020 General $248 5
2019 General $988 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Westbrook
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Benjamin Westbrook were reported at $124. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Benjamin Westbrook Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $988 $886 $178–$3,167 $163
2020 $248 $341 $108–$1,605 $114
2021 $1,889 $453 $125–$1,886 $132
2022 $590 $695 $180–$2,566 $149
2023 $2,789 $745 $205–$2,662 $160
2024 $220 $799 $214–$2,967 $164
2025 $124 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $2,278 23 payments
  2. Intuitive Surgical, Inc. $1,591 11 payments
  3. Abbott Laboratories $912 19 payments
  4. Silk Road Medical, Inc. $808 8 payments
  5. Atricure, Inc. $480 10 payments
  6. Inari Medical, Inc. $210 2 payments
  7. Medtronic, Inc. $152 2 payments
  8. Boston Scientific Corporation $101 1 payment
  9. Maquet Cardiovascular U.S. Sales, L.L.C. $84 2 payments
  10. Cook Medical LLC $65 1 payment
  11. Other $167 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $2,941 19 payments
  2. Food and Beverage $2,855 65 payments
  3. Education $1,051 3 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System Surgery $1,000 1 payment
  2. ENROUTE Transcarotid Neuroprotection System $808 8 payments
  3. ENROUTE Transcarotid Stent $808 8 payments
  4. ENHANCE Transcarotid Peripheral Access Kit $808 8 payments
  5. ENROUTE .014 Guidewire $808 8 payments
  6. Da Vinci Surgical System Surgery $591 10 payments
  7. AMPLATZER Occluders $349 1 payment
  8. EPIC $308 13 payments
  9. SYNERGY ABLATION SYSTEM $307 6 payments
  10. Tendyne Mitral Valve System $231 3 payments
  11. Other $1,565 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 123 billing codes

Paid by Medicare

$262,697

Medicare's payments for the services billed

Medicare patients

253

Average age 75

Services billed

677

99 women, 154 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 71%
Heart failure 44%
Arthritis 44%
Atrial fibrillation 43%
Chronic kidney disease 36%
Diabetes 33%
COPD 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

87 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record